BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 1111462)

  • 1. Clinical classification of plasma cell myeloma.
    Conklin R; Alexanian R
    Arch Intern Med; 1975 Jan; 135(1):139-43. PubMed ID: 1111462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring myelomatosis.
    Hobbs JR
    Arch Intern Med; 1975 Jan; 135(1):125-30. PubMed ID: 1111461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solitary plasmacytoma of bone and asymptomatic multiple myeloma.
    Dimopoulos MA; Moulopoulos A; Delasalle K; Alexanian R
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):359-69. PubMed ID: 1582978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of abnormal immunoglobulin with clinical features of myeloma.
    Arch Intern Med; 1975 Jan; 135(1):46-52. PubMed ID: 1111470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IV. Detection and differentiation of M-proteins by the acid-gel reaction--a re-evaluation.
    Daniels JC; Cobb EK; Levin WC; Ritzmann SE
    Tex Rep Biol Med; 1970; 28(4):541-5. PubMed ID: 4995465
    [No Abstract]   [Full Text] [Related]  

  • 6. [Gamma-D-paraproteinemia. Clinical case contribution based on 2 studies].
    Spengler GA; Bütler R; Pflugshaupt R; Lopez V; Barandun S
    Schweiz Med Wochenschr; 1967 Feb; 97(6):170-8. PubMed ID: 4175061
    [No Abstract]   [Full Text] [Related]  

  • 7. IgD multiple myeloma. Review of 133 cases.
    Jancelewicz Z; Takatsuki K; Sugai S; Pruzanski W
    Arch Intern Med; 1975 Jan; 135(1):87-93. PubMed ID: 1111472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis of paraproteinemic hemoblastoses].
    Fateh-Moghadam A
    Fortschr Med; 1976 May; 94(14):821-8. PubMed ID: 818002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognosis of multiple myeloma].
    Morell A; Skvaril F; Rüst HP; Spengler GA; Brunner K; Barandun S
    Schweiz Med Wochenschr; 1970 Nov; 100(46):1990-2. PubMed ID: 5507847
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 patients.
    Katodritou E; Terpos E; Symeonidis AS; Pouli A; Kelaidi C; Kyrtsonis MC; Kotsopoulou M; Delimpasi S; Christoforidou A; Giannakoulas N; Viniou NA; Stefanoudaki E; Hadjiaggelidou C; Christoulas D; Verrou E; Gastari V; Papadaki S; Polychronidou G; Papadopoulou A; Giannopoulou E; Kastritis E; Kouraklis A; Konstantinidou P; Anagnostopoulos A; Zervas K; Dimopoulos MA
    Am J Hematol; 2014 Aug; 89(8):803-8. PubMed ID: 24757085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal gammopathy in lymphoma.
    Alexanian R
    Arch Intern Med; 1975 Jan; 135(1):62-6. PubMed ID: 1089397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal immunoglobulins in multiple myeloma: effect of melphalan chemotherapy.
    Alexanian R; Migliore PJ
    J Lab Clin Med; 1970 Feb; 75(2):225-33. PubMed ID: 5414404
    [No Abstract]   [Full Text] [Related]  

  • 13. Significance of M-components in plasma cell myeloma and related disorders.
    Kano T
    Tohoku J Exp Med; 1970 Dec; 102(4):341-67. PubMed ID: 4101555
    [No Abstract]   [Full Text] [Related]  

  • 14. [2 new cases of initial or secondarily non-excreting plasma cell myelomas].
    Prost A; Soulilou JP; Gardais J; Hurez D; Cottin S
    Rev Rhum Mal Osteoartic; 1973 Feb; 40(2):151-7. PubMed ID: 4574504
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of plasma cell myeloma with cytotoxic agents.
    Bergsagel DE; Pruzanski W
    Arch Intern Med; 1975 Jan; 135(1):172-6. PubMed ID: 803363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The behavior of immunoglobulin in monoclonal gammopathies and their classification and pathogenesis.
    Kano T
    Tohoku J Exp Med; 1970 Dec; 102(4):369-401. PubMed ID: 4102668
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria.
    Sirohi B; Powles R; Kulkarni S; Rudin C; Saso R; Lal R; Singhal S; Mehta J; Horton C; Treleaven J
    Bone Marrow Transplant; 2001 Jul; 28(1):29-37. PubMed ID: 11498741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple myeloma without initial paraproteins.
    Kim I; Harley JB; Weksler B
    Am J Med Sci; 1972 Oct; 264(4):267-75. PubMed ID: 4630526
    [No Abstract]   [Full Text] [Related]  

  • 19. [Silent onset of multiple myeloma. How to diagnosis and when to treat?].
    Bartl R
    Internist (Berl); 1986 Mar; 27(3):192-200. PubMed ID: 3086250
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypoalbuminemia in patients with multiple myeloma.
    Chen YH; Magalhaes MC
    Arch Intern Med; 1990 Mar; 150(3):605-10. PubMed ID: 2310279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.